Eledon Pharmaceuticals, Inc. — Income Charts
5 years of history · ending 2017-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Operating Expenses
Income Breakdown
Revenue
$0
R&D↓-83.4% -$10M
$2M
D&A↑+120.0% +$12K
$22K
Operating Income↑+16.7% +$3M
$-13M
EBITDA↑+16.8% +$3M
$-13M
Other Income/Expense
$5K
Pretax Income
$-13M
Tax Provision
$0
Net Income↑+16.6% +$3M
$-13M
Effective Tax Rate
0.0%
Deferred Tax Assets
$0
Deferred Tax Liabilities
$0
DTA Valuation Allowance↓-79.4% -$19M
$5M
Tax Credit Carryforwards↓-89.3% -$794K
$95K
NOL Carryforwards↑+13.2% +$527K
$5M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory↑+69.0pts
35.0%
ETR State + Local (pp)
5.2%
Operating Lease Cost↑+173.2% +$634K
$1M
Income YoY Variation↓-92.7pts
-155.9%